✦ LIBER ✦

FP36-WE-06 Evaluation of efficacy, safety and tolerability of interferon beta 1b in patients of Chinese origin with multiple sclerosis

✍ Scribed by C. Lv; X.H. Zhang; L.Y. Cui; X.H. Xu; E.W. Radue; L.R. Wang; K. Beckmann; J. Lampe; C. Pohl; B. Stemper; R. Sandbrink

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FP36-WE-05 Add-on therapy with mitoxantr

✍ P. Hradilek; O. Zapletalova; I. Woznicova; R. Höfer 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Evaluation of efficacy, safety and toler

✍ Maciejek, Zdzisław; Wójcik-Drączkowska, Hanna; Wawrzyniak, Sławomir; Niezgodzińs 📂 Article 📅 2013 🏛 Termedia Publishing House 🌐 Polish ⚖ 77 KB

PND15 COST-UTILITY OF INTERFERON BETA-1B

✍ JP Caloyeras; C Wang; L Bauer; WC Lee; V Lanius; K Gondek 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PND26 COST-UTILITY OF INTERFERON BETA-1B

✍ T Arbizu; C Piñol; V Casado 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

0564 Long-term sustained efficacy and sa

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Evaluation of an electronic diary for im

✍ Zettl, Uwe K; Bauer-Steinhusen, Ulrike; Glaser, Thomas; Hechenbichler, Klaus; Li 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 278 KB